Yolanda Díz Chaves-rekin lankidetzan egindako argitalpenak (17)

2024

  1. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

  2. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

    Neural Regeneration Research, Vol. 19, Núm. 8, pp. 1617-1677

2022

  1. Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

    International journal of molecular sciences, Vol. 23, Núm. 17

  2. Effects of Glucagon-like peptide 1 (GLP-1) analogs in the hippocampus

    Vitamins and Hormones (Academic Press Inc.), pp. 457-478

  3. Renin–Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins

    Metabolites, Vol. 12, Núm. 5

2020

  1. GLP-1 receptor agonist ameliorates experimental lung fibrosis

    Scientific Reports, Vol. 10, Núm. 1

  2. Glucagon-like peptide-1 (GLP-1) in the integration of neural and endocrine responses to stress

    Nutrients, Vol. 12, Núm. 11, pp. 1-32

2019

  1. Perinatal undernutrition, metabolic hormones, and lung development

    Nutrients, Vol. 11, Núm. 12

2018

  1. Liraglutide enhances the activity of the Ace-2/Ang(1-7)/Mas receptor pathway in lungs of Male pups from food-restricted mothers and prevents the reduction of SP-A

    International Journal of Endocrinology, Vol. 2018

  2. The GLP-1 analog, liraglutide prevents the increase of proinflammatory mediators in the hippocampus of male rat pups submitted to maternal perinatal food restriction 11 Medical and Health Sciences 1109 Neurosciences

    Journal of Neuroinflammation, Vol. 15, Núm. 1

2016

  1. Stressing diabetes? The hidden links between insulinotropic peptides and the HPA axis

    Journal of Endocrinology, Vol. 230, Núm. 2, pp. R77-R94

2007

  1. Ghrelin improves growth hormone responses to growth hormone-releasing hormone in a streptozotocin-diabetic model of delayed onset

    Journal of Endocrinological Investigation, Vol. 30, Núm. 4, pp. 298-305

  2. Prolactin-releasing peptide (PrRP) increases prolactin responses to TRH in vitro and in vivo

    Endocrine, Vol. 31, Núm. 2, pp. 119-124

2006

  1. Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures

    Endocrine, Vol. 29, Núm. 2, pp. 317-324

  2. Prolactina

    Endocrinología (Universidade de Vigo), pp. 81-88

2004

  1. Heparin increases prolactin and modifies the effects of FGF-2 upon prolactin accumulation in pituitary primary cultures

    Endocrine, Vol. 24, Núm. 2, pp. 131-136

2003

  1. Regulación de la secreción de gh en la diabetes experimental

    Regulación de la secreción de gh en la diabetes experimental